SARA CONN: Open Payments
NPI 1225704471 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 41 payments from 11 companies in 2025. Trend: 2023 $1,302 · 2024 $641 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $269 |
| Amgen Inc. | 12 | $143 |
| Novo Nordisk Inc | 4 | $64 |
| Exact Sciences Corporation | 2 | $37 |
| PFIZER INC. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Novartis Pharmaceuticals Corporation | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Dexcom, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
Products named: BREZTRI, FARXIGA, REPATHA, OTEZLA, Cologuard Collection Kit, EVENITY, Wegovy, LEQVIO.
Industry payments across IN — which companies pay providers there.
